Related Experiment Video
Updated: Sep 10, 2025

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
Pregnancy and Lactation Associated Bone Fragility.
1Faculty of Medicine, Memorial University of Newfoundland, Health Sciences Centre, Newfoundland, Canada A1B 3V6.
During reproduction, the maternal skeleton provides calcium for milk, leading to bone density loss, especially during lactation. While bone typically recovers, fractures can occur, questioning the need for pharmacotherapy.
Area of Science:
- Reproductive endocrinology
- Bone metabolism
- Mineral homeostasis
Background:
- The maternal skeleton is a crucial calcium reservoir, particularly during lactation.
- Skeletal resorption is hormonally regulated, increasing significantly during lactation.
- While typically transient, bone loss can rarely lead to fragility fractures.
Purpose of the Study:
- To review the epidemiology, pathophysiology, diagnostics, and treatment of skeletal complications during reproduction.
- To evaluate the necessity and efficacy of pharmacotherapy for bone loss in premenopausal women.
Main Methods:
- Mini-review of existing literature on skeletal changes during pregnancy and lactation.
- Discussion of diagnostic criteria and therapeutic approaches.
- Analysis of the role of pharmacotherapy and the need for clinical trials.
Main Results:
- Lactation causes 5-10% spinal bone density loss, independent of calcium intake.
- Fragility fractures, including vertebral compression fractures, can occur, especially if pre-pregnancy bone health was compromised.
- The skeleton generally recovers post-weaning, even after fractures, casting doubt on routine pharmacotherapy.
Conclusions:
- Skeletal changes during reproduction are usually reversible, but fractures can occur.
- The necessity and optimal agents for pharmacotherapy in premenopausal women with reproductive-related bone loss remain uncertain.
- Further randomized trials are required to guide treatment decisions.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Osteoclasts in Bone Remodeling

